TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07217717: Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

Sponsor: SOFIE · Phase: PHASE3 · Area: ONCOLOGY · Target Enrollment: 200 pts

Competing Trials Overlap

12 Active Trials

Excess Burn Exposure

$4,329,864

Rescue Site Savings

+$2,886,576

Unlock Full NCT07217717 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07217717 Rescue Dossier →